Notably, both compounds suppressed the expression of major CSC markers, such as integrin α6, CD133, CD44, ALDH1A1, Nanog, Oct4, and Sox2, through the dual downregulation of CypA/CD147 and EGFR in NSCLC CSCs. The gene discussed is SOX2; the disease is non-small cell lung carcinoma.